Press Releases Select Year 2025 2024 2023 2022 2021 Select Year Apr 28, 2025 Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock Apr 25, 2025 Lexaria Announces $2 Million Registered Direct Offering of Common Stock Apr 23, 2025 Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience's Technology Apr 3, 2025 Lexaria Updates its Ongoing Human Study GLP-1-H24-4 Apr 2, 2025 Lexaria's Human GLP-1 Study #5 Begins Dosing First | Previous | Next | Last
